Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.769 EUR | +2.26% | -2.04% | +78.84% |
Mar. 11 | Sensorion: study results in hearing loss | CF |
Mar. 11 | Sensorion Meets Primary Endpoint for Sens-401 Phase 2A Clinical Study for Residual Hearing Preservation | CI |
Sales 2024 * | 18.85M 20.35M | Sales 2025 * | 18.95M 20.45M | Capitalization | 207M 224M |
---|---|---|---|---|---|
Net income 2024 * | -28M -30.22M | Net income 2025 * | -40M -43.17M | EV / Sales 2024 * | 8.29 x |
Net cash position 2024 * | 51M 55.05M | Net cash position 2025 * | 5M 5.4M | EV / Sales 2025 * | 10.7 x |
P/E ratio 2024 * |
-6.02
x | P/E ratio 2025 * |
-4.85
x | Employees | 57 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.3% |
1 day | -5.59% | ||
1 week | -9.55% | ||
Current month | -21.98% | ||
1 month | -19.32% | ||
3 months | +69.25% | ||
6 months | +5.03% | ||
Current year | +65.12% |
Managers | Title | Age | Since |
---|---|---|---|
Nawal Ouzren
CEO | Chief Executive Officer | 45 | 17-04-11 |
Bernd Schmidt
CTO | Chief Tech/Sci/R&D Officer | - | Dec. 10 |
Géraldine Honnet
CTO | Chief Tech/Sci/R&D Officer | - | 20-02-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cédric Moreau
BRD | Director/Board Member | - | - |
Khalil Barrage
CHM | Chairman | 59 | - |
John Furey
BRD | Director/Board Member | 59 | 19-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.769 | +2.26% | 89 557 |
24-03-27 | 0.752 | -7.05% | 160,141 |
24-03-26 | 0.809 | -3.69% | 50,595 |
24-03-25 | 0.84 | 0.00% | 25,642 |
24-03-22 | 0.84 | +7.01% | 62,008 |
Real-time Euronext Paris, March 28, 2024 at 07:23 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+65.12% | 224M | |
+9.16% | 45.97B | |
+54.26% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |